Clinical Trial
Beneficial effect of recombinant human glycosylated granulocyte colony-stimulating factor in marrow-transplanted patients: results of multicenter phase II-III studies
Affiliations
- PMID: 1703350
Item in Clipboard
Clinical Trial
Beneficial effect of recombinant human glycosylated granulocyte colony-stimulating factor in marrow-transplanted patients: results of multicenter phase II-III studies
Transplant Proc.
1991 Feb.
No abstract available
Similar articles
-
Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.Exp Hematol. 1995 Dec;23(14):1520-6. Exp Hematol. 1995. PMID: 8542941
-
Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation.Bone Marrow Transplant. 1993 Apr;11(4):307-11. Bone Marrow Transplant. 1993. PMID: 7683552 Clinical Trial.
-
Hematopoietic growth factors in autologous bone marrow transplantation.Semin Oncol. 1993 Oct;20(5 Suppl 6):88-95. Semin Oncol. 1993. PMID: 7692607 Review.
-
Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.Bone Marrow Transplant. 1996 Jan;17(1):31-7. Bone Marrow Transplant. 1996. PMID: 8673051
-
Granulocyte colony stimulating factor.J Fla Med Assoc. 1994 Jul;81(7):467-9. J Fla Med Assoc. 1994. PMID: 7525857 Review.
Cited by
-
Cytokines and bone marrow transplantation.J Cancer Res Clin Oncol. 1995;121(12):701-9. doi: 10.1007/BF01213315. J Cancer Res Clin Oncol. 1995. PMID: 7499440 Free PMC article. Review.
-
Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings.Drugs. 1995 May;49(5):767-93. doi: 10.2165/00003495-199549050-00009. Drugs. 1995. PMID: 7541335 Review.
-
Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.Ann Hematol. 1993 Dec;67(6):267-76. doi: 10.1007/BF01696346. Ann Hematol. 1993. PMID: 7506580 Clinical Trial.
-
Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings.Drugs. 2000 Mar;59(3):681-717. doi: 10.2165/00003495-200059030-00017. Drugs. 2000. PMID: 10776839 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical